ARCHIVES

The Antineoplaston Anomaly: How A Drug Was Used For Decades In Thousands Of Patients, With No Safety, Efficacy Data

This article is from The Cancer Letter archive.

Vol. 24 No. 36 | September 25, 1998

Download PDF Visit The Full Archive

Related Articles

Breast Cancer Coalition Demonstrations Crucial To Obtaining Windfall

October 16, 1992

Also in this 8-page issue: NIH Conflict of Interest panel recommends that NIH employees should not receive stock options or equities as compensation for outside work.

May 7, 2004

Senate Approves $1 Billion For NCI

July 27, 1979

Consensus Conference On Localized Prostate Cancer June 15-17

November 21, 1986

Dial Access Offers Caner Consultation Services

February 21, 1975

Letter to The Editor: IOM Panel Urges Greater Integration Of Research

February 12, 1999